Follicular Lymphoma Lab Tests Explained: How Blood, Biopsy, and Imaging Tests Impact Treatment Decisions
Join us on Tuesday, August 12, 2025 at 3pm PDT | 6pm EDT (U.S.)
How do blood test results help guide care for follicular lymphoma (FL)? What do terms like CBC, LDH, beta-2 microglobulin, and FLIPI really mean—and how are they used in monitoring and treatment planning?
In this in-depth discussion, Stephanie Chuang speaks with FL expert Dr. Celeste Bello of Moffitt Cancer Center. Together, they walk through the most important blood work and imaging tools in FL, when and how they’re used. They cover what biopsy types matter most, and how criteria like FLIPI, POD24, and GELF help determine when to start treatment.
Topics:
What blood tests and scans reveal in FL—and when they matter most
Biopsies and diagnostic tools: flow cytometry, IHC, and imaging
Understanding prognostic tools like FLIPI, POD24, and GELF criteria
Monitoring during observation and treatment: labs, scans, and red flags
Why speaking up about subtle changes can shape your care plan
Thank you to The Leukemia & Lymphoma Society for their partnership. The Leukemia & Lymphoma Society is here for you with information about clinical trials, resources, and dedicated support through their Information Specialists.
Register for this informative program then invite a Friend or Care Partner.
This program is designed to empower patients and care partners with clarity around tests—and when to speak up.
